anti phospho stat5 (Cell Signaling Technology Inc)
Cell Signaling Technology Inc is a verified supplier 
Cell Signaling Technology Inc manufactures this product 
96
Structured Review
Cell Signaling Technology Inc
anti phospho stat5
Anti Phospho Stat5, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1227 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stat5/Phospho-Stat5+(Tyr694)+Antibody/pmc13018901-4-0-2
Average 96 stars, based on 1227 article reviews
Anti Phospho Stat5, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1227 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stat5/Phospho-Stat5+(Tyr694)+Antibody/pmc13018901-4-0-2
Average 96 stars, based on 1227 article reviews
anti phospho stat5 - by Bioz Stars,
2026-10
96/100 stars
Images
Related Articles
Centrifugation:Article Title: Engineered probiotics for tumor-targeted combination chemoimmunotherapy Article Snippet: .. Cells were then collected by centrifugation (450 g , 5 min), and boiled in 1× SDS loading dye for WB detection of Western Blot:Article Title: Engineered probiotics for tumor-targeted combination chemoimmunotherapy Article Snippet: .. Cells were then collected by centrifugation (450 g , 5 min), and boiled in 1× SDS loading dye for WB detection of Incubation:Article Title: Targeting TLK2 with antisense oligonucleotides as a new strategy in acute myeloid leukemia Article Snippet: Lysates were separated through SDS polyacrylamide gels (4-12%) and transferred to a nitrocellulose membrane (Bio-Rad). .. Membranes were blocked with 5% BSA in 0.1% Tween20 in 1x PBS (PBS-T) for 1 hr at room temperature, followed by incubation with primary antibodies diluted in 5% BSA in PBST overnight at 4 °C included: TLK2 (#A301-257A, Bethyl Laboratories); Cell-Signaling:Article Title: ILC2-derived IL-9 activates regulatory T cells to facilitate post-myocardial infarction repair. Article Snippet: Primary antibodies included: anti-IL-9 (Abcam, Cat. No. ab227037), anti-Sirt1 (Cell Signaling Technology, Cat. No. 2028), anti-Ac-lysine (Santa Cruz, Cat. No. sc-32268), anti-acetyl STAT5B (Lys694) (Sigma-Aldrich, Cat. No. 09-007), anti-FOXP3 (Abclonal, Cat. No. A27170), anti-Phospho-STAT5 (Cell Signaling Technology, .. AR TIC LE IN PR ES S ARTICLE IN PRESS Cat. No. 9351), other:Article Title: New selective and allosteric FLT3 inhibitors show efficacy against resistant acute myeloid leukemia cells Article Snippet: Activity Assay:Article Title: Platforms for co-stimulation, novel car designs and other enhancements for adoptive cellular therapy Article Snippet: In some embodiments, a selective NF-κB activator induces more than 20% (e.g., more than 30%, 40%, 50%, 60%, 70%, 80%, 90%, 100%) increase in NF-κB activity as measured by Phospho-IκBα (Ser32) antibody (e.g., 14D4, Clone Cell Signaling Technology; Danvers, MA) but less than 20% increase in the activity of the STAT pathway as measured using Phospho-Stat3 (Tyr705) antibody (e.g., Clone D3A7, Cell Signaling Technology; Danvers, MA) when exposed to or expressed in a test human T cell as compared to a control human T cell. .. In some embodiments, a selective NF-κB activator induces more than 20% (e.g., more than 30%, 40%, 50%, 60%, 70%, 80%, 90%, 100%) increase in NF-κB activity as measured by Phospho-IκBα (Ser32) antibody (e.g., 14D4, Clone Cell Signaling Technology; Danvers, MA) but less than 20% increase in the activity of the Article Title: Platforms for co-stimulation, novel car designs and other enhancements for adoptive cellular therapy Article Snippet: In some embodiments, a selective NF-κB activator induces more than 20% (e.g., more than 30%, 40%, 50%, 60%, 70%, 80%, 90%, 100%) increase in NF-κB activity as measured by Phospho-NF-κB p65 (Ser536) antibody (Cell Signaling Technology; Danvers, MA) but less than 20% increase in the activity of the STAT pathway as measured using Phospho-Stat3 (Tyr705) antibody (e.g., Clone D3A7, Cell Signaling Technology; Danvers, MA) when exposed to or expressed in a test human T cell as compared to a control human T cell. .. In some embodiments, a selective NF-κB activator induces more than 20% (e.g., more than 30%, 40%, 50%, 60%, 70%, 80%, 90%, 100%) increase in NF-κB activity as measured by Phospho-NF-κB p65 (Ser536) antibody (Cell Signaling Technology; Danvers, MA) but less than 20% increase in the activity of the Control:Article Title: Platforms for co-stimulation, novel car designs and other enhancements for adoptive cellular therapy Article Snippet: In some embodiments, a selective NF-κB activator induces more than 20% (e.g., more than 30%, 40%, 50%, 60%, 70%, 80%, 90%, 100%) increase in NF-κB activity as measured by Phospho-IκBα (Ser32) antibody (e.g., 14D4, Clone Cell Signaling Technology; Danvers, MA) but less than 20% increase in the activity of the STAT pathway as measured using Phospho-Stat3 (Tyr705) antibody (e.g., Clone D3A7, Cell Signaling Technology; Danvers, MA) when exposed to or expressed in a test human T cell as compared to a control human T cell. .. In some embodiments, a selective NF-κB activator induces more than 20% (e.g., more than 30%, 40%, 50%, 60%, 70%, 80%, 90%, 100%) increase in NF-κB activity as measured by Phospho-IκBα (Ser32) antibody (e.g., 14D4, Clone Cell Signaling Technology; Danvers, MA) but less than 20% increase in the activity of the Article Title: Platforms for co-stimulation, novel car designs and other enhancements for adoptive cellular therapy Article Snippet: In some embodiments, a selective NF-κB activator induces more than 20% (e.g., more than 30%, 40%, 50%, 60%, 70%, 80%, 90%, 100%) increase in NF-κB activity as measured by Phospho-NF-κB p65 (Ser536) antibody (Cell Signaling Technology; Danvers, MA) but less than 20% increase in the activity of the STAT pathway as measured using Phospho-Stat3 (Tyr705) antibody (e.g., Clone D3A7, Cell Signaling Technology; Danvers, MA) when exposed to or expressed in a test human T cell as compared to a control human T cell. .. In some embodiments, a selective NF-κB activator induces more than 20% (e.g., more than 30%, 40%, 50%, 60%, 70%, 80%, 90%, 100%) increase in NF-κB activity as measured by Phospho-NF-κB p65 (Ser536) antibody (Cell Signaling Technology; Danvers, MA) but less than 20% increase in the activity of the |